Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
Background New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of...
Main Authors: | Pascale Lehoux, Fiona A. Miller, Geneviève Daudelin, Jean-Louis Denis |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2017-09-01
|
Series: | International Journal of Health Policy and Management |
Subjects: | |
Online Access: | http://www.ijhpm.com/article_3314_d55516fc36042b9d4d8e93b9053f3a4a.pdf |
Similar Items
-
A roadmap toward implementing health technology assessment in Egypt
by: Ahmad Nader Fasseeh, et al.
Published: (2022-12-01) -
New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
by: Nassim Parvizi, et al.
Published: (2017-12-01) -
What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
by: Oriol Solà-Morales, et al.
Published: (2025-01-01) -
Organizational structure and funding of health technology assessment agencies around the world
by: G. R. Khachatryan, et al.
Published: (2019-07-01) -
Health Technology Assessment (HTA) and health policy making: a narrative review
by: Anuji Upekshika Gamage, et al.
Published: (2020-11-01)